{"cik":1720725,"taxonomy":"us-gaap","tag":"InventoryNet","label":"Inventory, Net","description":"Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.","entityName":"Oyster Point Pharma, Inc.","units":{"USD":[{"end":"2020-12-31","val":0,"accn":"0001720725-22-000028","fy":2021,"fp":"FY","form":"10-K","filed":"2022-02-24","frame":"CY2020Q4I"},{"end":"2021-12-31","val":6086000,"accn":"0001720725-22-000028","fy":2021,"fp":"FY","form":"10-K","filed":"2022-02-24"},{"end":"2021-12-31","val":6086000,"accn":"0001720725-22-000048","fy":2022,"fp":"Q1","form":"10-Q","filed":"2022-05-05"},{"end":"2021-12-31","val":6086000,"accn":"0001720725-22-000072","fy":2022,"fp":"Q2","form":"10-Q","filed":"2022-08-11"},{"end":"2021-12-31","val":6086000,"accn":"0001720725-22-000080","fy":2022,"fp":"Q3","form":"10-Q","filed":"2022-11-10","frame":"CY2021Q4I"},{"end":"2022-03-31","val":4094000,"accn":"0001720725-22-000048","fy":2022,"fp":"Q1","form":"10-Q","filed":"2022-05-05","frame":"CY2022Q1I"},{"end":"2022-06-30","val":6645000,"accn":"0001720725-22-000072","fy":2022,"fp":"Q2","form":"10-Q","filed":"2022-08-11","frame":"CY2022Q2I"},{"end":"2022-09-30","val":6959000,"accn":"0001720725-22-000080","fy":2022,"fp":"Q3","form":"10-Q","filed":"2022-11-10","frame":"CY2022Q3I"}]}}